Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cochlear Implants Market, by Fitting Type
1.4.2 North America Cochlear Implants Market, by End Use
1.4.3 North America Cochlear Implants Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Product Launches: 2019-Jul-2016-Jun) Leading Players
Chapter 4. North America Cochlear Implants Market by Fitting Type
4.1 North America Unilateral Implantation Cochlear Implants Market by Country
4.2 North America Bilateral Implantation Cochlear Implants Market by Country
Chapter 5. North America Cochlear Implants Market by End Use
5.1 North America Pediatrics Market by Country
5.2 North America Adults Market by Country
Chapter 6. North America Cochlear Implants Market by Country
6.1 US Cochlear Implants Market
6.1.1 US Cochlear Implants Market by Fitting Type
6.1.2 US Cochlear Implants Market by End Use
6.2 Canada Cochlear Implants Market
6.2.1 Canada Cochlear Implants Market by Fitting Type
6.2.2 Canada Cochlear Implants Market by End Use
6.3 Mexico Cochlear Implants Market
6.3.1 Mexico Cochlear Implants Market by Fitting Type
6.3.2 Mexico Cochlear Implants Market by End Use
6.4 Rest of North America Cochlear Implants Market
6.4.1 Rest of North America Cochlear Implants Market by Fitting Type
6.4.2 Rest of North America Cochlear Implants Market by End Use
Chapter 7. Company Profiles
7.1 MED-EL GmbH
7.1.1 Company Overview
7.1.1 Recent strategies and developments:
7.1.1.1 Product launches:
7.1.1.2 Acquisitions and mergers:
7.2 Sonova Holding AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Product launches:
7.2.5.2 Expansions:
7.3 William Demant Holding A/S
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Collaborations, partnerships, and agreements:
7.4 Starkey laboratories, Inc.
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Collaborations, partnerships, and agreements:
7.4.2.2 Product launches:
7.5 GN Store Nord A/S (GN Hearing A/S)
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Recent strategies and developments:
7.5.4.1 Collaborations, partnerships, and agreements:
7.5.4.2 Product launches:
7.6 Amplifon SpA (Ampliter N.V.)
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Acquisitions and mergers:
7.7 Widex A/S
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Product launches:
7.7.2.2 Acquisitions and mergers:
7.8 Oticon Medical AB
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Collaborations, partnerships, and agreements:
7.8.2.2 Product launches:
7.9 Cochlear Ltd.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Collaborations, partnerships, and agreements:
7.9.5.2 Product launches:
7.9.5.3 Expansions:
7.1 Medtronic PLC
7.10.1 Company overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisitions and mergers:
Unique Offerings 